IL6 and prostate carcinoma: PI3K/Akt or MAPK/ERK signal activation triggered by IL-6 has been reported to induce cancer cell proliferation through the upregulation of cyclin A1 in hepatoma, prostate cancer, and multiple myeloma [36, 39, 40].